Trial document




drksid header

  DRKS00016658

Trial Description

start of 1:1-Block title

Title

Subjective factors influencing the course of ovarian cancer - a qualitative interview study of survivors

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

LISTEN

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

The present study aims to examine subjective factors influencing the course of ovarian cancer. For this purpose, survivors of ovarian cancer who were diagnosed at least 5 years ago will be interveiwed.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

The aim of this qualitative study is to analyze subjectve factors influencing the course of ovarian cancer. Femals with ovarian cancer, wich was diagnosed at least 5 years ago, will be interviewed by one semi-structured interview. The interview guide focuses on factors that positivly (or negativly) impact the patients' quality of life and coping with cancer.
The interviews will be audio-recorded, transcripted, anonymized, and analyzed by qualitative content analysis.

end of 1:1-Block scientific synopsis
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00016658
  •   2019/03/07
  •   [---]*
  •   yes
  •   Approved
  •   18-8390-BO, Ethik-Kommission der Medizinischen Fakultät der Universität Duisburg-Essen
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  •   U1111-1229-2184 
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   C56 -  Malignant neoplasm of ovary
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   There is no explicit study Intervention. Patients received treatment as usual according to clinical practice guidelines. They will be interviewed once by an semi-structured interview lasting 15 to 45 minutes.
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Other
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Subjektive factors influencing the course of disease and the quality of life
(explorative outcome - assesed by one semi-structured interview)

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

There are no secondary outcomes. All outcomes are explorative ones.

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • Medical Center 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2019/02/28
  •   40
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Female
  •   18   Years
  •   no maximum age
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

Age: 18 years, ovarian cancer, 5 years survival after FIGO IIIB, IIIC, IVA and IVB

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

- Severe physical or psychological comorbidity that do not allow a patient to participate in the study.
- Insufficient knowledge of the German language.

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen
    • Mr.  Prof. Dr. med.  Gustav  Dobos 
    • Am Deimelsberg 34a
    • 45276  Essen
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address other
    • Kliniken Essen-Mitte, Klinik für Gynäkologie & Gynäkologische Onkologie
    • Mr.  Prof. Dr. Dr. med.  Andreas  du Bois 
    • Henricistraße 40-42
    • 45136  Essen
    • Germany
    end of 1:1-Block address other
    start of 1:1-Block address contact other
    end of 1:1-Block address contact other
  • start of 1:1-Block address scientific-contact
    • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen
    • Ms.  Dr. rer. medic.  Heidemarie  Haller 
    • Am Deimelsberg 34a
    • 45276  Essen
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen
    • Ms.  Fatma  Sert 
    • Am Deimelsberg 34a
    • 45276  Essen
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Department of Internal and Integrative MedicineKliniken Essen-MitteFaculty of MedicineUniversity of Duisburg-Essen
    • Am Deimelsberg 34a
    • 45276  Essen
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact materialSupport
  • start of 1:1-Block address otherSupport
    • Karl und Veronica Carstens-Stiftung
    • Am Deimelsberg 36
    • 45276  Essen
    • Germany
    end of 1:1-Block address otherSupport
    start of 1:1-Block address contact otherSupport
    •   [---]*
    •   [---]*
    •   [---]*
    •   [---]*
    end of 1:1-Block address contact otherSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting ongoing
  •   [---]*
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

  • [---]*
end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.